Caplin Point falls 11% on disappointing Q4 results

The stock fell 11% to Rs 532 on the BSE in intra-day trade after the company's ebitda margin in March quarter declined by 400bps to 35% from 39% in previous year quarter.

Shares of Caplin Point Laboratories have fallen 11% to Rs 532 per share on the BSE in intra-day trade after the company’s ebitda (earnings before interest, taxation, depreciation and amortization) margin in March quarter (Q4FY18) declined 400bps to 35% from 39% in previous year quarter.

The company’s consolidated net profit during the quarter under review increased by 5.9% at Rs 353 million against Rs 333 million in the corresponding quarter of previous fiscal. Gross revenue grew 19% to Rs 1,463 million over the previous year quarter.

Caplin Point Laboratories' net profit growth was lowest since September 2013 quarter,